Positive efficacy and utility data presented during the 18th Annual Diabetes Technology Meeting Xeris Pharmaceuticals, Inc. (NASDAQ:XERS), a specialty pharmaceutical company leveraging...
Axeda Systems Announces Nasdaq Delisting MANSFIELD, Mass., July 7 /PRNewswire-FirstCall/ -- Axeda Systems Inc. (OTC:XEDA.PK), today announced that its common stock was delisted from The Nasdaq...
Axeda Systems Inc. Reports First Quarter 2005 Financial Results Record revenues and customer acquisition show momentum for DRM MANSFIELD, Mass., May 2 /PRNewswire-FirstCall/ -- Axeda Systems...
Axeda President to Speak at Field Service 2005 MANSFIELD, Mass., April 22 /PRNewswire-FirstCall/ -- Axeda Systems Inc. (NASDAQ:XEDAC), the world's leading provider of device relationship...
Axeda Systems Inc. Announces Date for Issuance of First Quarter 2005 Financial Results MANSFIELD, Mass., April 21 /PRNewswire-FirstCall/ -- Axeda Systems Inc. (NASDAQ:XEDAC), the world's leading...
Axeda Systems Publicly Announces Going Concern Qualification in Annual Filing MANSFIELD, Mass., April 18 /PRNewswire-FirstCall/ -- Axeda Systems Inc. (NASDAQ:XEDAC), the world's leading provider...
Respironics Licenses Axeda(R) DRM MANSFIELD, Mass., April 11 /PRNewswire-FirstCall/ -- Axeda Systems Inc. (NASDAQ:XEDAC), the world's leading provider of device relationship management (DRM...
Axeda Granted Extension from Nasdaq Listing Qualifications Panel MANSFIELD, Mass., March 25 /PRNewswire-FirstCall/ -- Axeda Systems Inc. (NASDAQ:XEDA), the world's leading provider of device...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales